Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri
- PMID: 19955273
- PMCID: PMC2815595
- DOI: 10.1128/JCM.00614-09
Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri
Abstract
Shigella spp. are the causative agent of shigellosis with Shigella flexneri serotype 2a being the most prevalent in developing countries. Epidemiological surveillance in China found that a new serotype of S. flexneri appeared in 2001 and replaced serotype 2a in 2003 as the most prevalent serotype in Henan Province. The new serotype also became the dominant serotype in 7 of the 10 other provinces under surveillance in China by 2007. The serotype was identified as a variant of serotype X. It differs from serotype X by agglutination to the monovalent anti-IV type antiserum and the group antigen-specific monoclonal antibody MASF IV-I. Genome sequencing of a serotype X variant isolate, 2002017, showed that it acquired a Shigella serotype conversion island, also as an SfX bacteriophage, containing gtr genes for type X-specific glucosylation. Multilocus sequence typing of 15 genes from 37 serotype X variant isolates and 69 isolates of eight other serotypes, 1a, 2a, 2b, 3a, 4a, 5b, X, and Y, found that all belong to a new sequence type (ST), ST91. Pulsed-field gel electrophoresis revealed 154 pulse types with 655 S. flexneri isolates analyzed and identified 57 serotype switching events. The data suggest that S. flexneri epidemics in China have been caused by a single epidemic clone, ST91, with frequent serotype switching to evade infection-induced immunity to serotypes to which the population was exposed previously. The clone has also acquired resistance to multiple antibiotics. These findings underscore the challenges to the current vaccine development and control strategies for shigellosis.
Figures




Similar articles
-
Genomic portrait of the evolution and epidemic spread of a recently emerged multidrug-resistant Shigella flexneri clone in China.J Clin Microbiol. 2014 Apr;52(4):1119-26. doi: 10.1128/JCM.02669-13. Epub 2014 Jan 22. J Clin Microbiol. 2014. PMID: 24452172 Free PMC article.
-
Emergence of a novel Shigella flexneri serotype 4s strain that evolved from a serotype X variant in China.J Clin Microbiol. 2011 Mar;49(3):1148-50. doi: 10.1128/JCM.01946-10. Epub 2010 Dec 22. J Clin Microbiol. 2011. PMID: 21177890 Free PMC article.
-
Emergence of a novel Shigella flexneri serotype 1d in China.Diagn Microbiol Infect Dis. 2012 Nov;74(3):316-9. doi: 10.1016/j.diagmicrobio.2012.06.022. Epub 2012 Jul 31. Diagn Microbiol Infect Dis. 2012. PMID: 22858548
-
Keratitis due to Shigella flexneri.J Clin Microbiol. 2006 Jun;44(6):2291-4. doi: 10.1128/JCM.00481-06. J Clin Microbiol. 2006. PMID: 16757643 Free PMC article. Review.
-
Shigella Flexneri Serotypes: O-antigen Structure, Serotype Conversion, and Serotyping Methods.Oman Med J. 2023 Jul 31;38(4):e522. doi: 10.5001/omj.2023.65. eCollection 2023 Jul. Oman Med J. 2023. PMID: 37724320 Free PMC article. Review.
Cited by
-
Molecular characterization and analysis of high-level multidrug-resistance of Shigella flexneri serotype 4s strains from China.Sci Rep. 2016 Jul 4;6:29124. doi: 10.1038/srep29124. Sci Rep. 2016. PMID: 27374009 Free PMC article.
-
Shigella: A Highly Virulent and Elusive Pathogen.Curr Trop Med Rep. 2014 Jun 1;1(2):81-87. doi: 10.1007/s40475-014-0019-6. Curr Trop Med Rep. 2014. PMID: 25110633 Free PMC article.
-
Acquisition and loss of CTX-M plasmids in Shigella species associated with MSM transmission in the UK.Microb Genom. 2021 Aug;7(8):000644. doi: 10.1099/mgen.0.000644. Microb Genom. 2021. PMID: 34427554 Free PMC article.
-
Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion.Mol Microbiol. 2012 Jan;83(1):208-23. doi: 10.1111/j.1365-2958.2011.07927.x. Epub 2011 Dec 9. Mol Microbiol. 2012. PMID: 22111928 Free PMC article.
-
Characterization and Genomic Analysis of SFPH2, a Novel T7virus Infecting Shigella.Front Microbiol. 2018 Dec 14;9:3027. doi: 10.3389/fmicb.2018.03027. eCollection 2018. Front Microbiol. 2018. PMID: 30619123 Free PMC article.
References
-
- Adams, M. M., G. E. Allison, and N. K. Verma. 2001. Type IV O antigen modification genes in the genome of Shigella flexneri NCTC 8296. Microbiology 147:851-860. - PubMed
-
- Ahmed, A. M., K. Furuta, K. Shimomura, Y. Kasama, and T. Shimamoto. 2006. Genetic characterization of multidrug resistance in Shigella spp. from Japan. J. Med. Microbiol. 55:1685-1691. - PubMed
-
- Allison, G. E., and N. K. Verma. 2000. Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol. 8:17-23. - PubMed
-
- Buchrieser, C., P. Glaser, C. Rusniok, H. Nedjari, H. D'Hauteville, F. Kunst, P. Sansonetti, and C. Parsot. 2000. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38:760-771. - PubMed
-
- Carlin, N. I., and A. A. Lindberg. 1987. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 strains. Infect. Immun. 55:1412-1420. - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous